Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Emotional difficulties were consistently elevated among children and young people from low income households over a month of lockdown compared to those from higher income households.

Young child looking out of a window

The most recent report from the Co-SPACE (COVID-19 Supporting Parents, Adolescents, and Children in Epidemics) study highlights that:

  • Emotional and restless/attention difficulties (and behaviour difficulties for primary school aged children) were consistently elevated among children and young people from low income households over a month of lockdown compared to those from higher income households, with around two and a half times as many children experiencing significant problems in low income households.
  • Parents and carers from low income households reported that their children (aged 4 to 16 years) had higher levels of emotional difficulties, such as feeling unhappy, worried, being clingy and experiencing physical symptoms associated with worry than those from higher income households. Their children were also more fidgety and restless and had greater difficulty paying attention. Those with younger, primary school aged children also reported that their children were experiencing higher levels of behaviour difficulties, including temper tantrums, arguments and not doing what they were being asked to do by adults than those from higher incomes.

Read more about the report findings on the Department of Experimental Psychology website

The story is also available on the University of Oxford website

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.